ClinicalTrials.Veeva

Menu

Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty

Lantheus Medical Imaging logo

Lantheus Medical Imaging

Status and phase

Completed
Phase 4

Conditions

Coronary Restenosis
Diabetes Mellitus, Type 2

Treatments

Drug: Technetium Tc99m Sestamibi

Study type

Interventional

Funder types

Industry

Identifiers

NCT00162357
CARDIOLITE-406

Details and patient eligibility

About

The purpose of this clinical research study is determine if patients with diabetes that have undergone previous opening of a heart blockage may have a blockage that is not causing any symptoms that may be detected by imaging with Cardiolite.

Enrollment

106 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type II Diabetes on medication & angioplasty within the past 6 months.

Exclusion criteria

  • Myocardial infarction or repeat angioplasty with the past 5 months.
  • Unable to perform exercise or pharmacologic stress test.

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

8

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems